1 / 10

Hyperosmolar Hyperglycemic Nonketotic syndrome

Hyperosmolar Hyperglycemic Nonketotic syndrome. Presented by Dr Moosally Prepared by Mick Svoboda. HHNS. Definition Severe hyperglycemia w/ Serum glucose >600mg/dL Plasma osmolarity > 315mOsm/kg Bicarb > 15 Arterial pH > 7.3 Serum ketones - negative or mildly elevated Epidemiology

elwyn
Télécharger la présentation

Hyperosmolar Hyperglycemic Nonketotic syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hyperosmolar Hyperglycemic Nonketotic syndrome Presented by Dr Moosally Prepared by Mick Svoboda

  2. HHNS • Definition • Severe hyperglycemia w/ • Serum glucose >600mg/dL • Plasma osmolarity > 315mOsm/kg • Bicarb > 15 • Arterial pH > 7.3 • Serum ketones - negative or mildly elevated • Epidemiology • HHNS occurs less often than DKA, but has a much higher mortality.

  3. Pathophysiology • HHNS is attributed to three factors • Decreased insulin utilization • Increased gluconeogenesis & glycogenolysis • Impaired renal excretion of glucose • End result - hyperglycemia and volume depletion through osmotic diuresis. • Total body water losses can reach 8-12 liters • Lack of ketoacidosis in HHNS attributed to • Lower levels of counterregulatory hormones • High levels of endogenous insulin inhibiting lypolysis • Hyperosmolar state inhibiting lypolysis

  4. Clinical Features • Usually elderly • HHNS pts often present with abnormal vital signs and changes in mentation. • Common complaints are nonspecific • Weakness, anorexia, fatigue, cough, dyspnea, or abdominal pain. • Pts are often poorly controlled or newly diagnosed type 2 DM. • 30-50% of cases are assoc. w/ pneumonia or UTIs.

  5. Physical findings • Sxs range from subtle changes in VS and confusion to profound shock and coma. • Sxs correlate with degree of hyperglycemia and hyperosmolality. • Signs of volume depletion. • Poor skin turgor, dry mucous membranes, hypotension. • CNS sxs • Tremor, clonus, hyper/hyporeflexia, hemiplegia or hemisensory defects.

  6. Laboratory studies • Serum glucose • Electrolytes • Serum osmolality/osmolarity • BUN, creatinine • Ketones • CBC • EKG • Ancillary studies if indicated • UA, blood cultures, CXR, cardiac enz, pancreatic enz, ABGs, head CT and LP.

  7. Treatment • Key is to improve tissue perfusion • Fluid resuscitation • NS preferred • Initial rates of 500-1500 mL/h during first two hrs. • More conservative therapy for pts w/ cardiac ds. • Once hypotension, tachycardia, and urinary output improve fluid can be changed to 1/2NS. • D5 ½NS can be used once serum glucose reaches 250-300mg/dL.

  8. Treatment • Electrolytes • K+ • Initial levels may be normal or high in the presence of acidemia • Levels < 3.3mEq/L represents severe deficit and are at risk for dysrhythmias. • Replacement can begin once urinary output is assured. • Replace at a rate of 10-20mEq/h. • Na+ • Replaced rapidly w/ the amount of NS required for fluid resuscitation. • Mag and Phos • No current guidelines for random replacement in the ED.

  9. Treatment • Insulin • As in DKA IV administration preferred over IM or SubQ due to poor adsorption. • IV infusion at rate of 0.1 units/kg/h R insulin • Loading dose is optional • Once serum glucose reaches 250-300mg/dL fluid can be to D5 1/2NS and insulin can be decreased to 0.05units/kg/h.

  10. Disposition • Most pts will require admission in the ICU or monitoring for the first 24hrs of care.

More Related